Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Z Cherney

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Current Diabetes Reports|March 21, 2018
Renal Hyperfiltration in Adolescents with Type 2 Diabetes: Physiology, Sex Differences, and Implications for Diabetic Kidney DiseasePetter Bjornstad, David Z Cherney
Clinical Journal of the American Society of Nephrology : CJASN|March 10, 2020
Liraglutide for the Treatment of Type 2 Diabetes and Safety in Diabetic Kidney Disease: Liraglutide and Diabetic Kidney DiseaseDavid Z Cherney, Katherine R Tuttle
Nature Reviews. Nephrology|December 24, 2018
Sodium transport in diabetes: two sides to the coinJulie A Lovshin, David Z Cherney
Clinical Journal of the American Society of Nephrology : CJASN|November 20, 2019
Sodium Glucose Cotransporter 2 Inhibition Heralds a Call-to-Action for Diabetic Kidney DiseaseKatherine R Tuttle, David Z Cherney,
Canadian Journal of Kidney Health and Disease|July 9, 2020
Sodium-Glucose Cotransporter-2 Inhibitors in Nephrology Practice: A Narrative ReviewLisa Dubrofsky, Anand Srivastava, David Z Cherney
Current Diabetes Reports|July 20, 2015
Update on Estimation of Kidney Function in Diabetic Kidney DiseasePetter Bjornstad, David Z Cherney, David M Maahs
Current Opinion in Nephrology and Hypertension|June 6, 2017
Do effects of sodium-glucose cotransporter-2 inhibitors in patients with diabetes give insight into potential use in non-diabetic kidney disease?Harindra Rajasekeran, David Z Cherney, Julie A Lovshin
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 1, 2020
Renal physiology of glucose handling and therapeutic implicationsDavid Z Cherney, Mehmet Kanbay, Julie A Lovshin
Jornal Brasileiro De Nefrologia|September 14, 2020
Making a case for the combined use of SGLT2 inhibitors and GLP1 receptor agonists for cardiorenal protectionVikas S Sridhar, Lisa Dubrofsky, Jacinthe Boulet, et al.
Current Diabetes Reports|January 25, 2016
Diabetic Kidney Disease in Adolescents With Type 2 Diabetes: New Insights and Potential TherapiesPetter Bjornstad, David Z Cherney, David M Maahs, et al.
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Current Diabetes Reports|March 21, 2018
Renal Hyperfiltration in Adolescents with Type 2 Diabetes: Physiology, Sex Differences, and Implications for Diabetic Kidney DiseasePetter Bjornstad, David Z Cherney
Clinical Journal of the American Society of Nephrology : CJASN|March 10, 2020
Liraglutide for the Treatment of Type 2 Diabetes and Safety in Diabetic Kidney Disease: Liraglutide and Diabetic Kidney DiseaseDavid Z Cherney, Katherine R Tuttle
Nature Reviews. Nephrology|December 24, 2018
Sodium transport in diabetes: two sides to the coinJulie A Lovshin, David Z Cherney
Clinical Journal of the American Society of Nephrology : CJASN|November 20, 2019
Sodium Glucose Cotransporter 2 Inhibition Heralds a Call-to-Action for Diabetic Kidney DiseaseKatherine R Tuttle, David Z Cherney,
Canadian Journal of Kidney Health and Disease|July 9, 2020
Sodium-Glucose Cotransporter-2 Inhibitors in Nephrology Practice: A Narrative ReviewLisa Dubrofsky, Anand Srivastava, David Z Cherney
Current Diabetes Reports|July 20, 2015
Update on Estimation of Kidney Function in Diabetic Kidney DiseasePetter Bjornstad, David Z Cherney, David M Maahs
Current Opinion in Nephrology and Hypertension|June 6, 2017
Do effects of sodium-glucose cotransporter-2 inhibitors in patients with diabetes give insight into potential use in non-diabetic kidney disease?Harindra Rajasekeran, David Z Cherney, Julie A Lovshin
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 1, 2020
Renal physiology of glucose handling and therapeutic implicationsDavid Z Cherney, Mehmet Kanbay, Julie A Lovshin
Jornal Brasileiro De Nefrologia|September 14, 2020
Making a case for the combined use of SGLT2 inhibitors and GLP1 receptor agonists for cardiorenal protectionVikas S Sridhar, Lisa Dubrofsky, Jacinthe Boulet, et al.
Current Diabetes Reports|January 25, 2016
Diabetic Kidney Disease in Adolescents With Type 2 Diabetes: New Insights and Potential TherapiesPetter Bjornstad, David Z Cherney, David M Maahs, et al.
Pageof 7